180 related articles for article (PubMed ID: 7978893)
1. Positron-emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors.
Eriksson B; Lilja A; Ahlström H; Bjurling P; Bergström M; Lindner KJ; Långström B; Oberg K
Ann N Y Acad Sci; 1994 Sep; 733():446-52. PubMed ID: 7978893
[No Abstract] [Full Text] [Related]
2. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
Eriksson B; Bergström M; Lilja A; Ahlström H; Långström B; Oberg K
Acta Oncol; 1993; 32(2):189-96. PubMed ID: 7686763
[TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
4. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.
Orlefors H; Sundin A; Ahlström H; Bjurling P; Bergström M; Lilja A; Långström B; Oberg K; Eriksson B
J Clin Oncol; 1998 Jul; 16(7):2534-41. PubMed ID: 9667275
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
[TBL] [Abstract][Full Text] [Related]
7. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo J; Abós MD; Prats E; García F; Razola P
Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
[No Abstract] [Full Text] [Related]
8. Gut neuroendocrine tumors.
Hammond PJ; Bloom SR
Curr Ther Endocrinol Metab; 1994; 5():570-5. PubMed ID: 7704795
[No Abstract] [Full Text] [Related]
9. Standard imaging techniques for neuroendocrine tumors.
Bushnell DL; Baum RP
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
[TBL] [Abstract][Full Text] [Related]
10. [Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors].
Banzo J; Prats E; Razola P; García S; Alonso V; Velilla J; Freile E; Benito JL; García F; Ubieto MA; Tardín L; Abós MD
Rev Esp Med Nucl; 2005; 24(4):278-92. PubMed ID: 16122413
[No Abstract] [Full Text] [Related]
11. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H
Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography.
Sundin A; Eriksson B; Bergström M; Bjurling P; Lindner KJ; Oberg K; Långström B
Nucl Med Biol; 2000 Jan; 27(1):33-41. PubMed ID: 10755643
[TBL] [Abstract][Full Text] [Related]
13. [[Radioguided surgery in the treatment of gastro-entero-pancreatic neuroendocrine tumors] ].
Cirillo F; Bottini A; Lima G; Alquati P
Minerva Chir; 2000; 55(7-8):517-21. PubMed ID: 11140106
[TBL] [Abstract][Full Text] [Related]
14. Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.
Hoegerle S; Schneider B; Kraft A; Moser E; Nitzsche EU
Nuklearmedizin; 1999; 38(4):127-30. PubMed ID: 10392379
[TBL] [Abstract][Full Text] [Related]
15. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson CJ; Dehdashti F; Cutler PD; Schwarz SW; Laforest R; Bass LA; Lewis JS; McCarthy DW
J Nucl Med; 2001 Feb; 42(2):213-21. PubMed ID: 11216519
[TBL] [Abstract][Full Text] [Related]
16. Combined Indium-111 octreotide scintigraphy and low-dose computed tomography in localization of neuroendocrine tumors.
Kjaer A; Dreyer M
Clin Nucl Med; 2003 Jun; 28(6):506-8. PubMed ID: 12917538
[No Abstract] [Full Text] [Related]
17. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Pauwels S; Leners N; Fiasse R; Jamar F
Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
[No Abstract] [Full Text] [Related]
18. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
Ahlman H; Tisell LE; Wängberg B; Nilsson O; Forssell-Aronsson E; Fjälling M
Semin Oncol; 1994 Oct; 21(5 Suppl 13):21-8. PubMed ID: 7992076
[No Abstract] [Full Text] [Related]
19. [The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Chiti A; Spinelli A; Bombardieri E
Radiol Med; 1997 Oct; 94(4):362-70. PubMed ID: 9465244
[No Abstract] [Full Text] [Related]
20. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
